BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 240 filers reported holding BLUEBIRD BIO INC in Q2 2015. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $25,022,000 | +135.7% | 148,615 | +69.1% | 0.98% | +117.3% |
| Q1 2015 | $10,616,000 | -38.6% | 87,900 | -53.4% | 0.45% | -40.2% |
| Q4 2014 | $17,298,000 | +133.0% | 188,600 | -8.9% | 0.75% | +125.1% |
| Q3 2014 | $7,425,000 | +45.8% | 207,000 | +56.8% | 0.33% | +71.3% |
| Q2 2014 | $5,091,000 | – | 132,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 82,500 | $5,090,000 | 4.20% |
| RTW INVESTMENTS, LP | 122,576 | $7,563,000 | 2.85% |
| Eventide Asset Management | 587,677 | $36,260,000 | 2.36% |
| First Light Asset Management, LLC | 71,246 | $4,396,000 | 1.93% |
| ARK Investment Management | 75,645 | $4,667,000 | 1.70% |
| Taylor Wealth Management Partners | 39,118 | $2,414,000 | 1.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 302,027 | $18,635,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 40,000 | $2,468,000 | 0.58% |
| Artal Group S.A. | 422,536 | $26,070,000 | 0.58% |
| TURNER INVESTMENTS LLC | 21,020 | $1,297,000 | 0.52% |